and Wisconsin State Crime Laboratory-Milwaukee were the laboratories that participated in this validation study.
Materials and Methods
For the manufacturer's stressing studies, one component was altered as indicated while the other components remained constant. Unless noted otherwise, protocols in the PowerPlex ® 16 System technical manual TMD012 (14) were followed.
Instrument Calibrations and Variability
All developmental work was performed with instruments and micropipetters that were tested to ensure that they were within manufacturer-specified calibration settings. Using a large number of laboratories in the validation process also allowed a statistical approach to examine the variations encountered within the forensic community.
DNA for Developmental and Single Source Studies
Human DNA was isolated using phenol/chloroform extraction (15) from the non-cell lines B10, B15, B19, C2, and H9 (Promega). DNA from the cell lines 9947A and CCRF-SB were acquired from Promega. These templates were quantitated by spectrophotometric analysis using A 260 detection (15) . Standard samples for manufacturer's consistency and multiplex versus monoplex studies were obtained from the National Institutes of Standards and Technology (NIST, Gaithersburg, MD). Genomic #1, Genomic #4, Genomic 9947A, and Genomic 9948 from the NIST Standard Reference Materials (SRM 2391a) were amplified as monoplexes and all ten DNA standards in this kit were genotyped with the PowerPlex ® 16 System. Non-human species samples were obtained from the Palm Beach County Sheriff's Office Crime Laboratory (West Palm Beach, FL) and Clontech (Palo Alto, CA). Buccal swab, liquid blood, and dried blood on FTA ® paper (Whatman, Clifton, NJ) for the manufacturer's standard samples study were extracted and quantitated using the DNA IQ™ System (Promega). Non-probative casework studies used phenol /chloroform and Chelex (BioRad, Hercules, CA) extraction protocols. Sexual assault samples underwent a differential lysis (16) as part of the DNA extraction. Liquid blood was spotted for matrix and environmental studies. Most forensic samples were concentrated using Microcon ® devices (Millipore Corp., Bedford, MA) and quantitated using the Quantiblot™ system (Applied Biosystems, Foster City, CA) or ACES™ system (Life Technologies, Rockville, MD).
DNA Amplification
PCR amplifications utilized the commercial release of Promega's PowerPlex ® 16 System and AmpliTaq Gold ® DNA Polymerase (Applied Biosystems). Amplification reactions typically were performed using a Perkin-Elmer GeneAmp™ PCR System 9600 Thermal Cycler (Foster City, CA) and the amplification cycling parameters described in the PowerPlex ® 16 System technical manual (14) . However, the Perkin-Elmer GeneAmp ® PCR System 2400, 9700 and the Perkin-Elmer Thermal Cycler Model 480 were also examined. Amplification reactions generally contained 0.5 to 1 ng DNA in 25 L and used 10/20 or 10/22 cycling as described in the PowerPlex ® 16 System technical manual (14) . The sequences of the forward and reverse primers for each of the 16 loci are shown in Table  1 . In studies examining magnesium concentrations, MgCl 2 solution and Mg-free GoldST*R Buffer were provided by Promega.
Amplification Analysis
The PowerPlex ® 16 System employs four fluorescent dyes (7). Spectral resolution was established by Promega's GenePrint ® Matrix FL-JOE-TMR-CXR allowing evaluation of each fluorescent dye employed in the kit (17) . All analyses utilized the ILS 600 size standard and Allelic Ladder Mix ( Fig. 1) ® 310 Genetic Analyzers using 3 s or 5 s injection times. Instruments used POP4 polymer and 47 cm capillaries from Applied Biosystems. Generally, 1 L of amplified sample and ILS 600 were prepared in 24 L deionized formamide. Samples were denatured for 3 min at 95°C followed by quick cooling on ice. Some experiments, as noted, analyzed 1 L or 2 L of prepared sample on the ABI PRISM ® 377 DNA Sequencer with Long Ranger™ gels (BioWhittaker Molecular Applications, Rockland, ME). Sample preparations generally used 1 L of amplified sample, 0.5 L ILS 600 and 1.5 L Blue Dextran Loading Solution (Promega) and were denatured for 2 min at 95°C followed by quick cooling on ice.
Stutter Calculation
Sixty-two human templates were amplified using the 10/22 cycling protocol and were analyzed on the ABI PRISM ® 310 Genetic Analyzer. Stutter peaks (19) (20) (21) were determined as four bases smaller (n-4) than tetranucleotide repeats and five bases smaller (n-5) than pentanucleotide repeats (Ϯ0.5 bases). A high level of stringency was imposed to collect accurate stutter data. Stutter peaks were required to return to baseline (data with highly variable backgrounds were not used) and stutter peaks that fell in the repeat position between sister alleles two repeat units apart were not used (additive effect of n ϩ 4 and n -4 was seen in some loci). The actual peak heights did not exceed 5000RFU. Stutter was calculated by dividing the peak height of the stutter peak by the peak height of the true allele.
Results and Discussion
The performance of PCR-based STR assays can be influenced by numerous factors including the differences in instrumentation, variability in the quality and quantity of the DNA being amplified, precision of sizing standard and variations in the reaction and analysis conditions. Each of these factors was evaluated for its affect on the completeness and correctness of genotypes provided with the PowerPlex ® 16 System. Additionally, the average stutter for each locus and the cross reactivity with non-human species were evaluated for the PowerPlex ® 16 System.
Variation of Cycle Number and Injection Time
A level of flexibility can be provided in an STR typing system by alteration of amplification cycle number. Higher cycle number can increase signal while decrease in cycle number can achieve a balanced signal when DNA template is in excess (>1 ng). As PCR cycling conditions have a major affect on the amount of product and the balance between loci, variations in the number of PCR cycles around the recommended 10/20 to 10/22 cycle protocols were evaluated (Fig. 2) . Cycle protocols between 10/18 and 10/26 (28 and 36 cycles, respectively) were evaluated using a titration of templates between 0.2 and 5 ng. As expected, a decrease in cycle number produced decreased peak heights with yield of the smaller loci being affected most. Locus dropout was observed with 0.5 ng template or less at 28 cycles. Five nanograms of template countered the effect of 28 cycles. Consequently, amplifications that inherently use excess templates, such as FTA punches, produce balanced peak heights across loci with decreased cycle number (personal communication, Susanne Brenneke, Missouri State Highway Patrol). A good balance was produced with 10/20 and 10/22 cycle protocols with roughly a 40% difference in signal intensity between conditions. Increases in cycle number (34 and 36 cycles) produced only a slight increase in yield for the largest loci while the smaller loci displayed a substantial increase in signal leading to notable imbalance between loci. Although increased cycle number may be useful in low copy number situations, the stochastic effects inherent in these amplifications increase the likelihood of heterozygote allele imbalance (see below).
An examination of peak heights under various cycling and injection times was performed by 19 different laboratories to address the issue of differing sensitivities of ABI PRISM ® 310 Genetic Analyzers. Figure 3 demonstrates a five-fold variation in average peak heights using 0.5 ng of template, 10/22 cycling, and 3 s injections. This variation does not appear to be the result of differences in thermal cyclers as the variation is also reflected in the internal lane standard, which is not amplified. To overcome this inherent variation, each laboratory selected the best one of four conditions between 10/20 and 10/22 cycling at either 3 or 5 s injections to obtain the peak heights recommended in the PowerPlex ® 16 System technical manual. Most laboratories selected 10/20 cycling with 5 sec injection or 10/22 cycling with 3 s injection.
Variation of Reaction Volume
Reduction of reaction volume, which is often used as a cost-saving measure, can alter the concentration of PCR reaction components. Varied reaction volumes were evaluated to determine the effects on amplification (Fig. 4) . Two approaches can be used in changing volume, keeping the template concentration constant or keeping the quantity of template constant. We elected to keep the concentration constant to reduce the effects of using high template concentrations, such as high background and saturation of the CCD pixels that may lead to too much or incomplete spectral subtraction resulting in phenomena known as pull down or pull up. Reaction volumes ranged from 5 L to 50 L (25 L volume standard) with template titrations between 0.2 and 5 ng/25 L. As expected, sig- nal intensity remained similar at all volumes tested. However, increased heterozygote allele imbalance was seen with reaction volumes of 10 L (0.2 ng) or less. This is likely due to stochastic effects resulting from the low amount of template. Decreased reaction volume may be a useful adaptation for very low template protocols as it effectively increases the concentration of a given amount of template. However, stochastic effects and corresponding concentration of inhibitors are all potential concerns.
AmpliTaq Gold ® DNA Polymerase Titration
The DNA polymerase plays a key role in determining the amount of amplification that can occur. Therefore, variations in the concentration of this enzyme were evaluated (Fig. 5) . Between 2 and 16U/25 L (0.5X-4X) were examined with 10/20 and 10/22 cycling and template ranges between 0.2-5 ng. Optimal balance of signal between loci was seen at 1X enzyme (4U). No locus dropout was observed with reduced enzyme but lower yield was noted in the larger loci. An increase in enzyme concentration produced a minimal increase in signal of several loci with 1ng or less template and a notable increase in the signal of most loci with 5 ng template (data not shown). 
Primer Pair Titration
The concentrations of the 32 primers play a critical role in the amplification efficiency of each locus. This required the manufacturer to adjust the primer concentrations to produce equivalent signals for each locus. Primer concentrations between 0.5X and 2X were tested with 10/20 and 10/22 cycles and template between 0.2 and 5ng to determine the effects on peak height and balance between loci (Fig. 6 ). When primer concentration was increased above 1X, smaller loci (in bases) were preferentially amplified. As primer concentration was decreased below 1X, peak heights decreased in small loci and increased in larger loci. Locus dropout was seen at 0.5X primer concentration and low template (0.2 ng) (data not shown). These data suggest that normal variability in pipetting precision will have minimal effect but intentional changes in primer concentration should not be made.
Titration of Magnesium
Magnesium plays an important role in polymerase activity and specificity (22) . Although magnesium is part of the reaction buffer, EDTA in the DNA sample can inadvertently alter effective con- centrations of magnesium. To examine the effect of magnesium variations, concentrations between 1-2 mM (1.5 mM is standard) were examined using 10/20 and 10/22 cycles and 1 ng of template (Fig. 7) . Optimal balance between loci was seen at 1.5 mM magnesium. Increased magnesium concentration produced a slight increase in the yield of smaller loci. A magnesium concentration of 1.25 mM resulted in locus-to-locus imbalance with 10/22 cycling and actual dropout of D3S1358, D18S51, and D5S818 loci with 10/20 cycling in some reactions (data not shown). Dropout of over 12 loci was seen in reactions using 1 mM magnesium. These results indicate that small increases in the magnesium concentration had little effect but a decrease in the magnesium concentration (i.e., adding large amounts of EDTA with sample DNA) could adversely affect results by chelating magnesium. For this reason, the manufacturer recommends storing samples in water or TE Ϫ4 (Tris, pH 8.0, 0.1 mM EDTA).
Variation of Annealing Temperature
Changes to the annealing temperature of the amplification reaction can affect the specificity and balance of the amplified loci. To examine these effects, amplification reactions were performed using annealing temperatures up to 4°C above and below the 60°C recommended annealing temperature with both 10/20 and 10/22 cycling conditions and DNA between 0.2 and 5 ng per reaction (Fig. 8) . Locus dropout and additional artifacts were not observed with lower annealing temperature but an increase in the yield of smaller loci causing locus to locus imbalance was noted. An increase to 62°C produced a decrease in yield of D3S1358, D5S818, D7S820 and amelogenin relative to other loci in 0.5-5ng reactions. At 64°C, dropout or near dropout of D3S1358, D18S51, D5S818, D7S820, Penta E, amelogenin, and D8S1179 was observed. These data suggest that the chosen annealing temperature has a 2°C leeway above and at least a 4°C range below.
Comparison of Thermal Cyclers
Different models of thermal cyclers have slightly different heating and cooling properties. To see what affect these differences have on amplification using the PowerPlex ® 16 System, four different thermal cycler models-the Perkin-Elmer GeneAmp ® PCR System 2400, 9600, 9700 and the Perkin-Elmer Thermal Cycler Model 480 using the 10/22 cycling protocols described in the tech- nical manual were examined. No consistent performance differences were observed (data not shown).
Genotype Consistency/Reproducibility
One key aspect of any amplification system is the ability to provide reproducible results in a variety of laboratory settings. To test this, 24 laboratories genotyped single source samples at 1.0, 0.5, and 0.25 ng of input DNA. After optimizing cycle number and injection times for their instruments, all laboratories were able to reliably genotype samples containing 1.0 and 0.5 ng of DNA. Only two laboratories had difficulty detecting two alleles using 0.25 ng of DNA due in part to low instrument sensitivity combined with signal thresholds of 150 RFU. Thus, even with the variations in ABI PRISM ® 310 Genetic Analyzer sensitivities, correct genotyping under a variety of input DNA concentrations was reliably obtained by a large group of laboratories (data not shown).
In addition to genotyping analyses between laboratories, monoplex and multiplex amplification reactions were performed using standard samples from NIST. All monoplex and PowerPlex ® 16 System derived genotypes were consistent with the NIST determined genotypes (data not shown).
Heterozygote Allele Balance, Sensitivity and Stochastic Effects
Accurate genotyping requires balanced heterozygous alleles. Imbalance can result from one allele amplifying slightly better than another or from sampling variations (stochastic effects) in samples with very few template molecules. Twenty-four laboratories examined the peak height balance of 16 heterozygote allele pairs (384 total pairs) using 0.25-1 ng single source DNA samples. At 1 ng, the mean ratio of heterozygote peak heights was 0.90 with a standard deviation of 0.085 Table (Table 2 ). This balance ratio dropped to 0.87 and 0.84 as the amount of input DNA was reduced to 0.5 ng and 0.25 ng, respectively.
Seven laboratories examined general heterozygote allele balance, allele dropout, sensitivity, and stochastic effects using single source samples from 0.0625-2 ng. Six of the seven laboratories were able to accurately genotype all 32 alleles using 0.125 ng DNA. Even at 0.0625 ng DNA, three of the laboratories were able to obtain a complete genotype (data not shown). However, as noted below, stochastic effects became significant at the lower DNA concentrations and could present difficulties analyzing samples containing DNA from more than one individual. Figure 9 shows the effect of DNA quantity on heterozygote allele balance. The degree of imbalance was divided into three categories: severe imbalance (ratio of peak heights of heterozygous alleles Ͻ0.5), moderate imbalance (ratio between 0.5 and 0.6), and slight imbalance (ratio between 0.6 and 0.7). Values greater than 0.7 were considered balanced. Above 0.25 ng template, slight to moderate imbalance was noted at a very low level. At 0.25 ng, three laboratories observed at least one moderately imbalanced allele pair while at 0.125 ng and below, most laboratories observed at least one imbalance. Although the majority of allele pairs remained balanced at 0.0625 ng, each laboratory should examine where imbalances begin to occur and be aware of this phenomena when using low amounts of input DNA (so-called stochastic threshold).
Mixture Analysis
Mixture analysis plays an important role in many casework studies. To analyze the resolving power of the PowerPlex ® 16 System, fifteen laboratories analyzed mixture sets of B19 and H9 DNA (provided by Promega Corporation) where the ratio of one sample to the other was changed from 19:1 to 1:19. Total DNA was kept constant at 1 ng. Interpretation and minimum RFU cutoff values were set by each laboratory and followed their established guidelines. Most of the laboratories could identify all of the minor alle- les with ratios between 2:1 and 1:2 (Fig. 10) . As the ratios became more extreme, the percentage of minor alleles detected decreased, averaging about 50% at 9:1 and 1:9 and about 17% at 19:1 and 1:19. However, there was a great deal of variation from laboratory to laboratory depending on the sensitivity of their ABI PRISM ® 310 Genetic Analyzer, the amount of DNA used, and their RFU cutoff limit.
Analysis Using the ABI PRISM
® 377 DNA Sequencer
Most of the developmental work was performed using ABI PRISM ® 310 Genetic Analyzers. However, some developmental, validation and non-probative work was performed on the ABI PRISM ® 377 DNA Sequencer. The results obtained on the two instruments were similar with the major difference being some locus balance differences. The large loci on the ABI PRISM ® 377 DNA Sequencer had consistently higher peak heights than the small loci (data not shown). This difference did not interfere with the interpretation of the data. Laboratories utilizing the ABI PRISM ® 377 DNA Sequencer should evaluate different loading volumes (1 L or 2 L) to produce preferred signal intensity.
Average Stutter
Stutter has a significant affect on genotype analysis, especially in mixtures (19) (20) (21) . For this reason, each STR locus in the PowerPlex ® 16 System was evaluated for stutter (Fig. 11 ). Average stutter calculated was similar to a report by Finis (23) with low average stutter being observed in Penta D, Penta E, THO1, and TPOX.
Sizing Precision of ILS 600
The consistency of sizing provided by the ILS 600 size standard was assessed through comparing the sizing of alleles from 13 ladder injections. Sizes of each allele were determined using GeneScan ® Software and the Local Southern Method. The sizes were averaged and a standard deviation for each allele was plotted against allele size (bases, Fig. 12 ). Increased deviation (SD > 0.1 bases) was observed in Penta D, E, FGA, and D18S51 but never exceeded a SD of 0.2 bases. ILS 600 demonstrated the precision across the assay range necessary for sizing off-ladder variants. 
Nonhuman Studies
STR analysis of forensic samples relies on the specificity of primers to humans. This prevents confusion when analyzing samples containing animal or microbial DNA. To ensure that the PowerPlex ® 16 System demonstrates this specificity, a variety of species were examined. No amplification was seen in mouse, rat, rabbit, chicken, E. faecalis, E. coli, P. aeruginosa, S. aureus, Hepatitus B virus, Human Papilloma virus, or C. albicans and a low level of amplification was seen in the amelogenin size range for dog and cow (data not shown). Amplification throughout the assay size range was seen in primates (Table 3) . Similar results were seen when cross reactive templates were assayed with monoplexes. Except for primates, none of the samples tested of animal, bacteria, or viral origin yielded any amplified products for the STR loci examined. Furthermore, the primates tested did not amplify at all 16 loci and often produced alleles that had migration patterns inconsistent with known human alleles. These results are consistent with results obtained with other forensic STR systems (24) .
Standard Specimens
To demonstrate that the sampling method does not alter genotype patterns, liquid blood, dried bloodstain cards (FTA ® paper), and buccal samples were taken from a single subject and genotyped with the PowerPlex ® 16 System. Complete, correct, and identical genotypes were obtained from DNA extracted from the three sources (data not shown). Additionally, common database samples were used extensively in the concordance studies for the PowerPlex ® 16 System (8,9).
Environmental Studies
Exposure to temperature and sunlight exposure can affect the quality of DNA resulting in degradation of larger templates and thus decreasing yield of larger amplicons (24) . To evaluate the PowerPlex ® 16 System, DNA was extracted from blood spots that were exposed to summertime light and temperature (Pennsylvania) and laboratory-controlled temperatures of 80, 50, room temperature, and 4°C. All spots were sampled on a time course of 3, 6, 12, 25, 48, and 85 days. Only samples exposed to 80°C displayed partial loss of genotype with Penta E dropout at 12 days, and additional dropout of CSF1PO, Penta D, and FGA after 48 days. All samples exposed to 50°C or lower temperature and all samples that experienced the light exposure portion of the study produced complete genotypes (data not shown).
Matrix Studies
Presence of polymerase inhibitors in substrate materials can affect the performance of PCR-based assays (24) . To evaluate the PowerPlex ® 16 System, DNA samples extracted from blood spotted on medium blue denim with a texture of normal blue jeans, a navy blue leather shoe, stacked plywood, glass, a rusty bolt, a rusty pliers, an oily rag, a soiled automotive tire, and a maple tree leaf were analyzed. Complete and correct amplifications were produced on both the ABI PRISM ® 310 Genetic Analyzer and ABI PRISM ® 377 DNA Sequencer (data not shown).
Non-Probative Case Studies
Acceptance of a new genotyping system necessitates reevaluation of previously typed forensic samples. To evaluate the PowerPlex ® 16 System concordance with previously released products, 95 samples from 26 cases collectively were examined by seven laboratories. These analyses included several samples that contained DNA from more than one individual. These non-probative samples had been previously genotyped with RFLP, and Applied Biosystems' DQ/PM, AmpfᐉSTR ® Profiler Plus™, and/or AmpfᐉSTR ® COfiler™. Consistent results were found when compared with all previous analyses and all crime scene samples produced genotypes that were consistent with the appropriate reference samples. Heterozygote peak height balance was examined in 80 samples containing a single profile (36 crime scene samples). The average heterozygote peak height ratio was 0.87 with a standard deviation of 0.089 and a range of 0.84-0.91. There was no significant difference in peak height ratio between crime scene samples and reference samples (data not shown). 
Conclusion
Availability of validation data following TWGDAM guidelines reduces the burden of the individual laboratory to repeat a majority of the developmental findings. This allows a focus on determining optimal analysis parameters for each laboratory's instrumentation. The findings of this study, performed with commercially released reagents, suggest that the PowerPlex ® 16 System is robust in handling moderate changes to the preferred amplification protocol and to various sample sources. This multiplex system demonstrated a high level of sensitivity in obtaining complete genotypes and is primarily limited by stochastic effects inherent in PCR amplification. Reliability in the performance of the PowerPlex ® 16 System was demonstrated by the generation of consistent results both between 24 laboratories using standard samples and within seven laboratories using previously genotyped, non-probative evidence.
Previous studies of this multiplex system documented allele frequencies, characterized the loci, and obtained CODIS/NDIS approval for database and casework samples. This report, in addition to these previous studies, represents assessable documentation necessary to implement the PowerPlex ® 16 System's general use in the forensic community.
